Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial

INTRODUCTION: There is concern about excessive bleeding when low-molecular-weight heparins (LMWHs) are used for venous thromboembolism (VTE) prophylaxis in renal dysfunction. Our objective was to evaluate whether LMWH VTE prophylaxis was safe and effective in critically ill patients with renal dysfu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Pai, Menaka, Adhikari, Neill K. J., Ostermann, Marlies, Heels-Ansdell, Diane, Douketis, James D., Skrobik, Yoanna, Qushmaq, Ismael, Meade, Maureen, Guyatt, Gordon, Geerts, William, Walsh, Michael W., Crowther, Mark A., Friedrich, Jan O., Burry, Lisa, Bellomo, Rinaldo, Brandão da Silva, Nilton, Costa Filho, Rubens, Cox, Michael J., Alves Silva, Suzana, Cook, Deborah J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5983525/
https://ncbi.nlm.nih.gov/pubmed/29856817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0198285
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky